Melanotan-1 with Coffee Safety: Cardiovascular Load Comparison
Systolic BP Increase 8–12 mmHg 5–8 mmHg 13–20 mmHg Additive effect exceeds either compound alone; individuals with baseline hypertension (>130/85) may breach 150 mmHg threshold Heart Rate Increase 8–15 bpm 3–6 bpm 11–21 bpm Combined elevation frequently pushes
This comparison does not assign a generated winner or score.
- Systolic BP Increase
- 8–12 mmHg
- 5–8 mmHg
- 13–20 mmHg
- Additive effect exceeds either compound alone; individuals with baseline hypertension (>130/85) may breach 150 mmHg threshold
- Heart Rate Increase
- 8–15 bpm
- 3–6 bpm
- 11–21 bpm
- Combined elevation frequently pushes resting HR above 100 bpm during first week of melanotan-1 use before receptor downregulation occurs
- Duration of Effect
- 6–8 hours
- 4–6 hours
- 6–8 hours overlapping window
- Peak overlap occurs 2–4 hours post-injection if coffee consumed 30–90 minutes after administration
- Mechanism
- MC4R-mediated sympathetic activation
- Adenosine receptor antagonism
- Independent pathways converging on sympathetic tone
- No direct pharmacokinetic interaction but convergent physiological endpoints
- Tolerance Development
- Minimal (receptor density stable)
- Rapid (7–10 days)
- Partial (caffeine only)
- Caffeine tolerance does not reduce melanotan-1 cardiovascular response; combined load persists